M Basu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Basu

Showing results (181-190 of 183) with videos related to

Pageof 19

Sort By:

You have reached the last page of results.This site can display upto 183 results.

European Journal of Cancer (Oxford, England : 1990)|March 14, 2025

Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusionsAmi V Desai, Aditi Bagchi, Amy E Armstrong, et al.

Neuro-Oncology|April 8, 2022

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)Ami V Desai, Giles W Robinson, Karen Gauvain, et al.

Cell|August 16, 2020

Extracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, et al.

Pageof 19

Search research articles

Showing results (181-190 of 183) with videos related to

Sort By:

Pageof 19

You have reached the last page of results.This site can display upto 183 results.

European Journal of Cancer (Oxford, England : 1990)|March 14, 2025

Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusionsAmi V Desai, Aditi Bagchi, Amy E Armstrong, et al.

Neuro-Oncology|April 8, 2022

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)Ami V Desai, Giles W Robinson, Karen Gauvain, et al.

Cell|August 16, 2020

Extracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, et al.

Pageof 19